Michelson Medical Research Foundation’s State Street SPDR S&P China ETF GXC Stock Holding History
Bought
Maintained
Sold
Other funds holding GXC
OPCM
SA
PA
SC
Michelson Medical Research Foundation's GXC Position: Q2 2026 in Review
Michelson Medical Research Foundation held its State Street SPDR S&P China ETF (GXC) position steady in Q2 2026 at 16,750 shares worth $1.45M. The position accounts for 1.34% of the portfolio, ranked #21.
Michelson Medical Research Foundation first reported a position in GXC in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.76M in Q3 2025. 74 funds tracked by Wall St. Rank hold GXC as of Q2 2026.
- Michelson Medical Research Foundation held 16,750 shares of State Street SPDR S&P China ETF worth $1.45M as of Q2 2026.
- Michelson Medical Research Foundation left its State Street SPDR S&P China ETF share count unchanged in Q2 2026.
- State Street SPDR S&P China ETF made up 1.34% of Michelson Medical Research Foundation's portfolio in Q2 2026, its #21 holding.
- Michelson Medical Research Foundation first reported a position in State Street SPDR S&P China ETF in Q4 2023 and has held it in 11 quarters since.
- Michelson Medical Research Foundation's State Street SPDR S&P China ETF position peaked at $1.76M in Q3 2025.
- 74 funds tracked by Wall St. Rank held State Street SPDR S&P China ETF as of Q2 2026.
Based on Michelson Medical Research Foundation's 13F filing for Q2 2026, filed 14 Aug 2026.